Cited by 1,311Fatty Acid Research and HealthAcute Myocardial Infarction ResearchCardiac Health and Mental Health

The DOI matches its Crossref record, with a small difference in title or year; 36 of the 36 references it cites were found in a registry or an index.

Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione

Marchioli, Roberto, Barzi, Federica, Bomba, Elena, Chieffo, Carmine, Di Gregorio, Domenico, Di Mascio, Rocco, Franzosi, Maria Grazia, Geraci, Enrico, Levantesi, Giacomo, Maggioni, Aldo Pietro, Mantini, Loredana, Marfisi, Rosa Maria, Mastrogiuseppe, G., Mininni, Nicola, Nicolosi, Gian Luigi, Santini, Massimo, Schweiger, Carlo, Tavazzi, Luigi, Tognoni, Gianni, Tucci, Corrado, Valagussa, Franco·2002·Circulation

DOI 10.1161/01.cir.0000014682.14181.f2

Open this paper in CoChat — free account

Abstract

Background — Our purpose was to assess the time course of the benefit of n-3 polyunsaturated fatty acids (PUFAs) on mortality documented by the GISSI-Prevenzione trial in patients surviving a recent (<3 months) myocardial infarction. Methods and Results — In this study, 11 323 patients were randomly assigned to supplements of n-3 PUFAs, vitamin E (300 mg/d), both, or no treatment (control) on top of optimal pharmacological treatment and lifestyle advice. Intention-to-treat analysis adjusted for interaction between treatments was carried out. Early efficacy of n-3 PUFA treatment for total, cardiovascular, cardiac, coronary, and sudden death; nonfatal myocardial infarction; total coronary heart disease; and cerebrovascular events was assessed by right-censoring follow-up data 12 times from the first month after randomization up to 12 months. Survival curves for n-3 PUFA treatment diverged early after randomization, and total mortality was significantly lowered after 3 months of treatment (relative risk [RR] 0.59; 95% CI 0.36 to 0.97; P =0.037). The reduction in risk of sudden death was specifically relevant and statistically significant already at 4 months (RR 0.47; 95% CI 0.219 to 0.995; P =0.048). A similarly significant, although delayed, pattern after 6 to 8 months of treatment was observed for cardiovascular, cardiac, and coronary deaths. Conclusions — The early effect of low-dose (1 g/d) n-3 PUFAs on total mortality and sudden death supports the hypothesis of an antiarrhythmic effect of this drug. Such a result is consistent with the wealth of evidence coming from laboratory experiments on isolated myocytes, animal models, and epidemiological and clinical studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000014682.14181.f2

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial
(1999) · The Lancet · doi:10.1016/s0140-6736(99)07072-5 · Cited by 3,812
Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction: Final Report of the Lyon Diet Heart Study
de Lorgeril, M., Salen, P., Martin, J.-L., Monjaud, I., Delaye, J., & Mamelle, N. (1999) · Circulation · doi:10.1161/01.cir.99.6.779 · Cited by 2,910
EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART)
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart Disease
Kromhout, D., Bosschieter, E. B., & Coulander, C. D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121901 · Cited by 2,177
Untitled work
(1999) · PubMed · Cited by 2,062
Self-citation
n-3 fatty acids and serum lipoproteins: human studies
Harris, W. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1645s · Cited by 1,243
Fish Consumption and Risk of Sudden Cardiac Death
Albert, C. M. (1998) · JAMA · doi:10.1001/jama.279.1.23 · Cited by 990
The Composition of Food Consumed by Greenland Eskimos
Bang, H. O., Dyerberg, J., & Hjørne, N. (1976) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1976.tb08198.x · Cited by 950
Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest.
Siscovick, D. S. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530170043030 · Cited by 920
Fish consumption and the 30-year risk of fatal myocardial infarction
Daviglus, M. L., Stamler, J., Orencia, A. J., Dyer, A. R., Liu, K., Greenland, P., Walsh, M. K., Morris, D., & Shekelle, R. B. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361502 · Cited by 902

Show all 36 references

Research works printed but not linked: 10

1997, Can J Physiol Pharmacol, 75, 234
10.1161/circ.94.5.952 · DOI
10.1161/circ.99.6.779 · DOI
2001, Eur Heart J, 22, D85
2001, Eur Heart J, 22, D98
1985, Cancer Treat Rep, 69, 1055
10.1161/circ.94.7.1774 · DOI
10.1161/circ.99.18.2452 · DOI
2001, Eur Heart J, 22, D42
2001, Eur Heart J, 22, D106

Sorted by citations

Items 601–700 of 1,000

Bioactive Foods and Nutraceutical Supplementation Criteria in Cardiovascular Protection
Sharma, R., & Singh, R. B. (2010) · The Open Nutraceuticals Journal · doi:10.2174/18763960010030300141 · Cited by 25
The combination of EPA+DHA and low-dose aspirin ingestion reduces platelet function acutely whereas each alone may not in healthy humans
Block, R., Kakinami, L., Jonovich, M. R., Antonetti, I., Lawrence, P., Meednu, N., Artero, P. C., Mousa, S. A., Brenna, J. T., & Georas, S. N. (2012) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2012.08.007 · Cited by 25
Eicosapentaenoic acid ameliorates palmitate-induced lipotoxicity via the AMP kinase/dynamin-related protein-1 signaling pathway in differentiated H9c2 myocytes
Sakamoto, A., Saotome, M., Hasan, P., Satoh, T., Ohtani, H., Urushida, T., Katoh, H., Satoh, H., & Hayashi, H. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.01.004 · Cited by 25
Therapeutic lifestyle change and adult treatment panel III: Evidence then and now
Stone, N. J., & Horn, L. V. (2002) · Current Atherosclerosis Reports · doi:10.1007/s11883-002-0047-x · Cited by 26
Omega-3 Fatty Acids and Arrhythmias
Marcus, M. D., & Link, M. S. (2024) · Circulation · doi:10.1161/circulationaha.123.065769 · Cited by 30
Exploring newer cardioprotective strategies: ω-3 fatty acids in perspective
Tremoli, E., Tufano, A., Russolillo, A., Lupoli, R., Minno, G. D., & Minno, M. N. D. D. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-01-0008 · Cited by 25
Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs
KONES, R. J., & Rumana, U. (2015) · Drugs · doi:10.1007/s40265-015-0429-3 · Cited by 26
A Meta-Analysis of Omega-3 Fatty Acids and Incidence of Atrial Fibrillation
Khawaja, O. A., Gaziano, J. M., & Djoussé, L. (2012) · Journal of the American College of Nutrition · doi:10.1080/07315724.2012.10720003 · Cited by 26
The effect of eicosapentaenoic and docosahexaenoic acids on physical function, exercise, and joint replacement in patients with coronary artery disease: A secondary analysis of a randomized clinical trial
Alfaddagh, A., Elajami, T. K., Saleh, M. A., Elajami, M. K., Bistrian, B. R., & Welty, F. K. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.03.080 · Cited by 24
Microbiota, a New Playground for the Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Diseases
Rousseau, G. (2021) · Marine Drugs · doi:10.3390/md19020054 · Cited by 25
LIPID, CHOLESTEROL AND FATTY ACID PROFILE OF SOME COMMERCIALLY IMPORTANT FISH SPECIES FROM SOUTH CASPIAN SEA
Pirestani, S., Sahari, M. A., Barzegar, M., & Nikoopour, H. (2010) · Journal of Food Biochemistry · doi:10.1111/j.1745-4514.2010.00343.x · Cited by 24
Influence of food components on lipid metabolism: scenarios and perspective on the control and prevention of dyslipidemias
Frota, K. D. M. G., Matias, A. C. G., & Arêas, J. A. G. (2010) · Food Science and Technology · doi:10.1590/s0101-20612010000500002 · Cited by 25
Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice
Rischio and Prevenzione Investigators (2010) · Trials · doi:10.1186/1745-6215-11-68 · Cited by 24
Limited Impact of 2 g/day Omega-3 Fatty Acid Ethyl Esters (Omacor®) on Plasma Lipids and Inflammatory Markers in Patients Awaiting Carotid Endarterectomy
Yusof, H. M., Cawood, A. L., Ren, D., Williams, J., Napper, F. L., Shearman, C. P., Grimble, R. F., Payne, S., & Calder, P. C. (2013) · Marine Drugs · doi:10.3390/md11093569 · Cited by 24
Influence of n-3 fatty acids on cardiac autonomic activity among Nunavik Inuit adults
Valéra, B., Dewailly, É., Anassour-Laouan-Sidi, E., & Poirier, P. (2011) · International Journal of Circumpolar Health · doi:10.3402/ijch.v70i1.17800 · Cited by 24
Association between Omega–3 Fatty Acids and Depressive Symptoms among Patients with Established Coronary Artery Disease: Data from the Heart and Soul Study
Ali, S., Garg, S. K., Cohen, B. E., Bhave, P. D., Harris, W. S., & Whooley, M. A. (2009) · Psychotherapy and Psychosomatics · doi:10.1159/000203118 · Cited by 24
Metabolic Syndrome - Theory and Practice
Ramić, E., Prasko, S., Batić-Mujanović, O., & Gavran, L. (2016) · Materia Socio Medica · doi:10.5455/msm.2016.28.71-73 · Cited by 25
Future of antiarrhythmic drugs
Darbar, D., & Roden, D. M. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000231407.61683.05 · Cited by 24
Docosahexaenoic Acid Enhances Hepatic Serum Amyloid A Expression via Protein Kinase A-dependent Mechanism
Tai, C. C., Chen, C., Lee, M., Wang, Y. C., Li, T., Mersamm, H. J., Ding, S., & Wang, P. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.024661 · Cited by 24
Fish oils, coronary heart disease, and the environment
Greene, J., Ashburn, S. M., Razzouk, L., & Smith, D. A. (2013) · American Journal of Public Health · doi:10.2105/ajph.2012.300959 · Cited by 23
Recent developments, challenges, and prospects of dietary omega-3 PUFA-fortified foods: Focusing on their effects on cardiovascular diseases
Wang, Y., Wu, G., Wang, Y., Rehman, A., Yu, L., Zhang, H., Jin, Q., Suleria, H. A. R., & Wang, X. (2024) · Food Chemistry · doi:10.1016/j.foodchem.2024.142498 · Cited by 25
Artificial Rearing of Infant Mice Leads to n‐3 Fatty Acid Deficiency in Cardiac, Neural and Peripheral Tissues
Hussein, N., Fedorova, I., Moriguchi, T., Hamazaki, K., Kim, H., Hoshiba, J., & Salem, N. (2009) · Lipids · doi:10.1007/s11745-009-3318-2 · Cited by 23
A fish a day, keeps the cardiologist away! – A review of the effect of omega-3 fatty acids in the cardiovascular system
Peter, S., Chopra, S., & Jacob, J. J. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.111630 · Cited by 26
Dietary supplementation with Lovaza and krill oil shortens the life span of long-lived F1 mice
Spindler, S. R., Mote, P. L., & Flegal, J. M. (2014) · AGE · doi:10.1007/s11357-014-9659-7 · Cited by 24
Omega-3 consumption and sudden cardiac death in schizophrenia
Scorza, F. A., Cysneiros, R. M., Terra, V. C., Scorza, C. A., Cavalheiro, É. A., Ribeiro, M. O., & Gattaz, W. F. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.06.008 · Cited by 23
The Role of Docosahexaenoic and Arachidonic Acids as Determinants of Evolution and Hominid Brain Development
Crawford, M. A., Broadhurst, C. L., Galli, C., Ghebremeskel, K., Holmsen, H., Saugstad, L. F., Schmidt, W., Sinclair, A. J., & Cunnane, S. C. (2008) · Cited by 23
Low Docosahexaenoic Acid, Dihomo-Gamma-Linolenic Acid, and Arachidonic Acid Levels Associated with Long-Term Mortality in Patients with Acute Decompensated Heart Failure in Different Nutritional Statuses
Ouchi, S., Miyazaki, T., Shimada, K., Sugita, Y., Shimizu, M., Murata, A., Kato, T., Aikawa, T., Suda, S., Shiozawa, T., et al. (2017) · Nutrients · doi:10.3390/nu9090956 · Cited by 24
Lipid-altering agents: the future
Wierzbicki, A. S. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2004.00087.x · Cited by 23
Omega-3 Fatty Acids: Anti-Arrhythmic, Pro-Arrhythmic, or Both?
von Schacky, C. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00088 · Cited by 23
N-3 polyunsaturated fatty acids attenuates triglyceride and inflammatory factors level in hfat-1 transgenic pigs
Liu, X., Pang, D., Yuan, T., Li, Z., Li, Z., Zhang, M., Ren, W., Ouyang, H., & Tang, X. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0259-7 · Cited by 24
Circulating Omega-6, But Not Omega-3 Polyunsaturated Fatty Acids, Are Associated with Clinical Outcomes in Patients with Acute Decompensated Heart Failure
Nagai, T., Honda, Y., Sugano, Y., Nishimura, K., Nakai, M., Honda, S., Iwakami, N., Okada, A., Asaumi, Y., Aiba, T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165841 · Cited by 24
Antiarrhythmic Drugs:
Roden, D. M. (2003) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2003.03441.x · Cited by 23
Baseline Plasma Fatty Acids Profile and Incident Cardiovascular Events in the SU.FOL.OM3 Trial: The Evidence Revisited
Fezeu, L., Laporte, F., Kesse‐Guyot, E., Andreeva, V. A., Blacher, J., Herçberg, S., & Galan, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092548 · Cited by 22
The Cardioprotective Effect of Vitamin E (Alpha-Tocopherol) Is Strongly Related to Age and Gender in Mice
Hu, X., Fu, L., Yan, L., Lin, Z., Liu, X., Wang, J., Chen, Y., Wang, Z., Zhang, X., Ou, Z., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137405 · Cited by 22
Importance of Fatty Acid Compositions in Patients with Peripheral Arterial Disease
Gautam, M., Izawa, A., Shiba, Y., Motoki, H., Takeuchi, T., Okada, A., Tomita, T., Miyashita, Y., Koyama, J., & Ikeda, U. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107003 · Cited by 23
A Comparison of the Two β-Blockers Carvedilol and Atenolol on Left Ventricular Ejection Fraction and Clinical Endpoints after Myocardial Infarction
Jónsson, G., Abdelnoor, M., Müller, C., Kjeldsen, S. E., Os, I., & Westheim, A. S. (2005) · Cardiology · doi:10.1159/000084584 · Cited by 22
Role of Olive Oil and Monounsaturated Fatty Acids in Mitochondrial Oxidative Stress and Aging
Quiles, J. L., Barja, G., Battino, M. A., Mataix, J., & Solfrizzi, V. (2006) · Nutrition Reviews · doi:10.1111/j.1753-4887.2006.tb00261.x · Cited by 25
Inflammation and its Association with Glucose Disorders and Cardiovascular Disease
Barzilay, J. I., & Freedland, E. S. (2003) · Treatments in Endocrinology · doi:10.2165/00024677-200302020-00002 · Cited by 22
(n-3) Fatty Acids Do Not Affect Electrocardiographic Characteristics of Healthy Men and Women
Geelen, A., Brouwer, I. A., Zock, P. L., Kors, J. A., Swenne, C. A., Katan, M., & Schouten, E. G. (2002) · Journal of Nutrition · doi:10.1093/jn/131.10.3051 · Cited by 22
Omega-3 Fatty Acid: A Role in the Management of Cardiac Arrhythmias?
Cheng, J. W. M., & Santoni, F. (2008) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2007.0765 · Cited by 21
Effect of Dietary Omega-3 Polyunsaturated Fatty Acids on Heart Rate and Heart Rate Variability in Animals Susceptible or Resistant to Ventricular Fibrillation
Billman, G. E. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00071 · Cited by 23
Use of Red Blood Cell Fatty-Acid Profiles as Biomarkers in Cardiac Disease
von Schacky, C. (2009) · Biomarkers in Medicine · doi:10.2217/17520363.3.1.25 · Cited by 21
Hypertriglyceridaemia with bexarotene in cutaneous T cell lymphoma: the role of omega‐3 fatty acids
Musolino, A., Panebianco, M., Zendri, E., Santini, M., Nuzzo, S. D., & Ardizzoni, A. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07596.x · Cited by 21
Self-citation
Advances in the management of hyperlipidemia-induced atherosclerosis
Tannock, L. R. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.369 · Cited by 21
(n-3) Long-Chain Polyunsaturated Fatty Acids Prolong Survival following Myocardial Infarction in Rats
Zaloga, G. P., Ruzmetov, N., Harvey, K. A., Terry, C. L., Patel, N. C., Stillwell, W. H., & Siddiqui, R. A. (2006) · Journal of Nutrition · doi:10.1093/jn/136.7.1874 · Cited by 21
Omega-3 Fatty Acids: The “Japanese” Factor?
Harris, W. S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.018 · Cited by 21
Metabolic syndrome and the older male population
Mazza, A. D., & Morley, J. E. (2007) · The Aging Male · doi:10.1080/13685530701249592 · Cited by 20
The cross-talk between the cGAS-STING signaling pathway and chronic inflammation in the development of musculoskeletal disorders
Kalinkovich, A., & Livshits, G. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102602 · Cited by 23
Mechanisms involved in the differential reduction of omega-3 and omega-6 highly unsaturated fatty acids by structural heart disease resulting in “HUFA deficiency”
Rupp, H., Rupp, T. P., Alter, P. J., & Maisch, B. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y11-101 · Cited by 20
Effects of omega-3, omega-6, and total dietary polyunsaturated fatty acid supplementation in patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis
Luo, S., Hou, H., Wang, Y., Li, Y., Zhang, L., Zhang, H., Jin, Q., Wu, G., & Wang, X. (2023) · Food & Function · doi:10.1039/d3fo02522e · Cited by 22
Lipoprotection in cardiovascular diseases
Benkhoff, M., & Polzin, A. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108747 · Cited by 20
Nutritional benefits of omega-3 fatty acids
Calder, P. C. (2013) · Elsevier eBooks · doi:10.1533/9780857098863.1.3 · Cited by 21
n−3 PUFAs in cardiovascular disease
Marchioli, R., & Levantesi, G. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.042 · Cited by 22
Self-citation
Aquaculture produces wholesome food: cultured fish as a valuable source of n-3 fatty acids
Steffens, W. (2015) · Aquaculture International · doi:10.1007/s10499-015-9885-8 · Cited by 20
Fish Oil and Cardiometabolic Diseases: Recent Updates and Controversies
Tummala, R., Ghosh, R. K., Jain, V., Devanabanda, A. R., Bandyopadhyay, D., DEEDWANIA, P. C., & Aronow, W. S. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.04.027 · Cited by 21
The case for adding eicosapentaenoic acid (icosapent ethyl) to the ABCs of cardiovascular disease prevention
Trivedi, K., Le, V. T., & Nelson, J. R. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1783937 · Cited by 20
Pesticide Toxicity to Fishes: Exposure, Toxicity and Risk Assessment Methodologies
Stanley, J., & Preetha, G. (2016) · Springer eBooks · doi:10.1007/978-94-017-7752-0_7 · Cited by 24
Adult cardiorenal benefits from postnatal fish oil supplement in rat offspring of low-protein pregnancies
Catta-Preta, M., Oliveira, D. A., Mandarim‐de‐Lacerda, C. A., & Águila, M. B. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.09.004 · Cited by 20
Treatment of dyslipidemia
Tonkin, A. M., & Byrnes, A. (2014) · F1000Prime Reports · doi:10.12703/p6-17 · Cited by 20
A review of the biologic and pharmacologic role of docosapentaenoic acid n-3
Yazdi, P. G. (2014) · F1000Research · doi:10.12688/f1000research.2-256.v2 · Cited by 21
The cost-effectiveness of omega-3 supplements for prevention of secondary coronary events.
Schmier, J. K., Rachman, N. J., & Halpern, M. T. (2006) · PubMed · Cited by 20
Plant sterols, marine-derived omega-3 fatty acids and other functional ingredients: a new frontier for treating hyperlipidemia
Marinangeli, C. P. F., & Jones, P. J. H. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-76 · Cited by 20
Omega-3 fatty acids in heart disease—why accurately measured levels matter
von Schacky, C., Kuipers, R. S., Pijl, H., Muskiet, F. A. J., & Grobbee, D. E. (2023) · Netherlands Heart Journal · doi:10.1007/s12471-023-01759-2 · Cited by 19
Association Between Serum Levels of n-3 Polyunsaturated Fatty Acids and Coronary Plaque Detected by Coronary Computed Tomography Angiography in Patients Receiving Statin Therapy
Urabe, Y., Yamamoto, H., Kitagawa, T., Utsunomiya, H., Tsushima, H., Tatsugami, F., Awai, K., & Kihara, Y. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0257 · Cited by 19
Nutritional Armor in Evolution: Docosahexaenoic Acid as a Determinant of Neural, Evolution and Hominid Brain Development
Crawford, M. A., Broadhurst, C. L., Cunnane, S. C., Marsh, D. E., Schmidt, W., Brand, A., & Ghebremeskel, K. (2014) · Military Medicine · doi:10.7205/milmed-d-14-00246 · Cited by 19
Untitled work
(2012) · PubMed · Cited by 19
n-3 Fatty acids and risk for fatal coronary disease
Harris, W. S., & Zotor, F. B. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665118002902 · Cited by 19
EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES IN PATIENTS WITH DIABETES AND PREDIABETES (2021)
Chazova, I. E., Shestakova, M. V., Zhernakova, Y. V., Blinova, N. V., Маркова, Т. Н., Mazurina, N. V., Владиславович, Е. М., Tereshchenko, S. N., Жиров, И. В., Komarov, A. L., et al. (2021) · Eurasian heart journal · doi:10.38109/2225-1685-2021-2-6-61 · Cited by 19
Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy
Patel, J. V. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4307 · Cited by 19
Marine omega-3 highly unsaturated fatty acids: From mechanisms to clinical implications in heart failure and arrhythmias
Glück, T., & Alter, P. J. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.03.007 · Cited by 20
Antiarrhythmic drugs
Singh, S. N., & Patrick, J. (2004) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-004-0019-2 · Cited by 19
The benefits of marine omega-3s for preventing arrhythmias
DiNicolantonio, J. J., & O’Keefe, J. H. (2020) · Open Heart · doi:10.1136/openhrt-2018-000904 · Cited by 19
Differential effects of EPA and DHA on PPARγ-mediated sympathetic innervation in infarcted rat hearts by GPR120-dependent and -independent mechanisms
Wang, C.-P., Lee, C.-C., Wu, D., Chen, S.-Y., & Lee, T. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.108950 · Cited by 19
N-3 polyunsaturated fatty acid supplementation does not reduce vulnerability to atrial fibrillation in remodeling atria
Ramadeen, A., Connelly, K. A., Leong-Poi, H. M., Hu, X., Fujii, H., Krieken, R. V., Laurent, G., Holub, B. J., Bazinet, R. P., & Dorian, P. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.02.013 · Cited by 18
The Role of Long-Chained Marine N-3 Polyunsaturated Fatty Acids in Cardiovascular Disease
Aarsetoey, H., Grundt, H., Nygaard, O. K., & Nilsen, D. W. T. (2012) · Cardiology Research and Practice · doi:10.1155/2012/303456 · Cited by 18
Nonprescription Medication Use in Patients With Heart Failure: Assessment Methods, Utilization Patterns, and Discrepancies With Medical Records
Mattila, M., Boehm, L. M., Burke, S., Kashyap, A., Holschbach, L., Miller, T., & Vardeny, O. (2013) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2013.10.009 · Cited by 18
Macronutrient and fatty acid profiles of meagre (Argyrosomus regius) fillets as influenced by harvesting time and boiling
Martelli, R., Zotte, A. D., Bonelli, A., Lupi, P., Franci, O., & Parisi, G. (2013) · Florence Research (University of Florence) · doi:10.4081/ijas.2013.e88 · Cited by 18
Antioxidants and Cardiovascular Disease: Still a Topic of Interest
Nojiri, S., Daida, H., & Inaba, Y. (2004) · Environmental Health and Preventive Medicine · doi:10.1007/bf02898101 · Cited by 18
Pesticide Toxicity to Parasitoids: Exposure, Toxicity and Risk Assessment Methodologies
Stanley, J., & Preetha, G. (2016) · Springer eBooks · doi:10.1007/978-94-017-7752-0_2 · Cited by 18
Refocussing therapeutic strategies for cardiac arrhythmias: defining viable molecular targets to restore cardiac ion flux
George, C. H., Barberini-Jammaers, S. R., & Müller, C. T. (2008) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.18.1.1 · Cited by 18
Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) in Cardiovascular Diseases (CVDs) and Depression: The Missing Link?
Chang, J. P.-C., Chen, Y.-T., & Su, K. (2009) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2009/725310 · Cited by 18
Omega-3 fatty acids for the treatment of elevated triglycerides
Maki, K. C., Dicklin, M. R., Lawless, A. L., & Reeves, M. P. (2009) · Clinical Lipidology · doi:10.2217/clp.09.34 · Cited by 18
Clinical use of and future perspectives on antiarrhythmic drugs
Estrada, J. C., & Darbar, D. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0555-x · Cited by 19
Fish, marine n-3 polyunsaturated fatty acids and coronary heart disease: A minireview with focus on clinical trial data
Schmidt, E. B., Rasmussen, L. H., Rasmussen, J. G., Joensen, A. M., Madsen, M. B., & Christensen, J. H. (2006) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.05.008 · Cited by 18
Alternative medicine in atrial fibrillation treatment-Yoga, acupuncture, biofeedback and more.
Kanmanthareddy, A., Reddy, M., Ponnaganti, G. C., Sanjani, H. P., Koripalli, S., Adabala, N. P., Buddam, A. R., Janga, P., Lakkireddy, T., Bommana, S., et al. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2015.01.13 · Cited by 17
Treatment with omega-3 fatty acid ethyl-ester alters fatty acid composition of lipoproteins in overweight or obese adults with insulin resistance
Augustine, A. H., Lowenstein, L. M., Harris, W. S., Shearer, G. C., & Block, R. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.12.003 · Cited by 18
n-3 Polyunsaturated Fatty Acids After Coronary Artery Bypass Grafting
Benedetto, U., Melina, G., Bartolomeo, R. D., Angeloni, E., Sansone, D., Falaschi, G. M., Capuano, F., Comito, C., Roscitano, A., & Sinatra, R. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2010.11.068 · Cited by 17
N-3 fatty acid supplementation to routine statin treatment inhibits platelet function, decreases patients’ daytime blood pressure, and improves inflammatory status
Doenyas‐Barak, K., Berman, S., Hamad, R. A., Golik, A., Rahimi‐Levene, N., & Efrati, S. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1235-4 · Cited by 17
n-3 fatty acids and cardiovascular disease
Grundt, H., & Nilsen, D. W. T. (2008) · Haematologica · doi:10.3324/haematol.13191 · Cited by 17
The future for long chain n-3 PUFA in the prevention of coronary heart disease: do we need to target non-fish-eaters?
Hall, W. L. (2017) · Proceedings of The Nutrition Society · doi:10.1017/s0029665117000428 · Cited by 19
Plasma fatty acid profiles: Relationships with sex, age, and state-reported heart disease mortality rates in the United States
Diffenderfer, M. R., Rajapakse, N., Pham, E., He, L., Dansinger, M. L., Nelson, J. R., & Schaefer, E. J. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.12.005 · Cited by 17
Reduced cardiac remodelling and prevention of glutathione deficiency after omega‐3 supplementation in chronic heart failure
Fang, Y., Favre, J., Vercauteren, M., Laillet, B., Rémy‐Jouet, I., Skiba, M., Lallemand, F., Dehaudt, C., Monteil, C., Thuillez, C., et al. (2010) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2010.00839.x · Cited by 18
Altered monocyte CD44 expression in peripheral arterial disease is corrected by fish oil supplementation
Madden, J., Shearman, C. P., Dunn, R. L., Dastur, N., Tan, R., Nash, G. B., Rainger, G. E., Brunner, A., Calder, P. C., & Grimble, R. F. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.06.011 · Cited by 17
Triglyceride-lowering agents
Salakhutdinov, N. F., & Laev, S. S. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.05.008 · Cited by 17
N-3 vs. n-6 fatty acids differentially influence calcium signalling and adhesion of inflammatory activated monocytes: impact of lipid rafts
Schaefer, M. B., Schaefer, C. A., Schifferings, S., Kuhlmann, C. R. W., Urban, A., Benscheid, U., Fischer, T., Hecker, M., Morty, R. E., Vadász, I., et al. (2016) · Inflammation Research · doi:10.1007/s00011-016-0971-9 · Cited by 17
Effect of supplemented intake of omega-3 fatty acids on arrhythmias in patients with ICD: fish oil therapy may reduce ventricular arrhythmia
Weisman, D., Beinart, R., Erez, A., Koren‐Morag, N., Goldenberg, I., Eldar, M., Glikson, M., & Luria, D. M. (2017) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-017-0267-1 · Cited by 17
Augmented bioavailability of felodipine through an α-linolenic acid-based microemulsion
Singh, M. V., Kanoujia, J., Parashar, P., Arya, M., Tripathi, C. B., Sinha, V. R., Saraf, S. K., & Saraf, S. A. (2017) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0453-9 · Cited by 17
Effect of icosapent ethyl on susceptibility to ventricular arrhythmias in postinfarcted rat hearts: Role of GPR120‐mediated connexin43 phosphorylation
Chen, W., Chen, S., Wu, D., Lee, C., & Lee, T. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15575 · Cited by 17
A cost-effectiveness analysis of n-3 PUFA (Omacor®) treatment in post-MI patients
Quilici, S., Martin, M., McGuire, A. J., & Zöllner, Y. F. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01009.x · Cited by 17
Reduced effect on apoptosis of 4-hydroxyhexenal and oxidized LDL enriched with n-3 fatty acids from postmenopausal women
Lee, Y., & Wander, R. C. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2004.09.006 · Cited by 17

Authors: Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., Mantini, L., Marfisi, R. M., Mastrogiuseppe, G., Mininni, N., Nicolosi, G. L., Santini, M., Schweiger, C., Tavazzi, L., Tognoni, G., Tucci, C., & Valagussa, F.
Affiliations: Mario Negri Institute for Pharmacological Research (IT)
From the Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti (R.M., F.B., E.B., R.D.M., R.M.M., G.T.); Ospedale Civile, Caserta (C.C.); Ospedale Civile, Lanciano (D.D.G., L.M., G.M., C.T.); Department of Cardiovascular Research, Istituto Mario Negri, Milano (M.G.F.); Ospedale Cervello, Palermo (E.G.); Ospedale Civile, Vasto (G.L.); Centro Studi ANMCO, Firenze (A.P.M.); Ospedale Civile, Napoli (N.M.); Ospedale S. Maria degli Angeli, Pordenone (G...
Corresponding author: Marchioli, Roberto
ORCID: Barzi, Federica
Chieffo, Carmine
Maggioni, Aldo Pietro
Nicolosi, Gian Luigi
Tavazzi, Luigi
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2002-04-23
Volume: 105
Issue: 16
Pages: 1897-1903
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.0000014682.14181.f2
OpenAlex: W2128788220
Cited by: 1,311
References: 36
Citations by year: 2026: 6 · 2025: 14 · 2024: 27 · 2023: 18 · 2022: 21 · 2021: 17 · 2020: 30 · 2019: 20 · 2018: 33 · 2017: 42 · 2016: 42 · 2015: 49 · 2014: 64 · 2013: 87 · 2012: 84
FWCI: 60.57
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: Bristol-Myers Squibb
Istituto di Ricerche Farmacologiche Mario Negri - IRCCS
Topics: Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords: omega-3 fatty acids, myocardial infarction, sudden death, mortality, vitamin E, antiarrhythmic effect, time course of treatment effects, cardiovascular mortality, coronary artery disease, cerebrovascular events
MeSH terms: Anti-Arrhythmia Agents, Female, Follow-Up Studies, Humans, Italy, Kinetics, Lipids, Male, Middle Aged, Myocardial Infarction, Fatty Acids, Omega-3, Death, Sudden, Cardiac, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks